InVivo Therapeutics has enrolled a sixth patient into the INSPIRE Study.
Here are four points:
1. The study examines the safety and efficacy of InVivo Therapeutics' Neuro-Spinal Scaffold in patients suffering from complete, thoracic spinal cord injury.
2. The patient has been enrolled at the Barnes-Jewish Hospital at Washington University Medical Center in St. Louis, which serves as a site of the study.
3. Wilson Ray, MD, an associate professor of neurosurgery and a member of The INSPIRE Study Steering Committee, implanted the scaffold in the patient.
4. The biodegradable Neuro-Spinal Scaffold is an investigational device that has received a 'humanitarian use device' designation from the FDA.